Clinical Trial Update: A 48-Week, Randomised, Study to Describe the Pharmacokinetic Profile and Durability of Atazanavir-Saquinavir-Ritonavir Once Daily and Describe the Pharmacokinetic Profile of Saquinavir-Ritonavir Using Saquinavir 500mg Formulation: the ASK-500 Study [NA]

View source ↗

Summary

Completed randomized pharmacokinetic study evaluating once-daily Atazanavir-Saquinavir-Ritonavir and Saquinavir-Ritonavir regimens, and describing the PK of a S…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• ATAZANAVIR (atazanavir)
• Ritonavir (Ritonavir)
• Saquinavir (saquinavir)

Snippet

Sponsor: Kirby Institute | Conditions: HIV Infections | NA | Status: COMPLETED